Lavipharm reaches agreement on debt restructuring

Lavipharm SA announced it has reached an agreement with creditor banks on a restructuring of its debt worth 26 million euros.

In an announcement, Lavipharm said the agreement envisages the extension of the debt maturity up to 2023, while the borrowing cost fell to 4.0 pct. The listed pharmaceuticals/cosmetics company has already signed a debt restructuring deal with Attica Bank Leasing, worth 12.5 million euros